These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 9760316

  • 1. Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle.
    Norman B, Mahnke-Zizelman DK, Vallis A, Sabina RL.
    J Appl Physiol (1985); 1998 Oct; 85(4):1273-8. PubMed ID: 9760316
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjects.
    Norman B, Sabina RL, Jansson E.
    J Appl Physiol (1985); 2001 Jul; 91(1):258-64. PubMed ID: 11408438
    [Abstract] [Full Text] [Related]

  • 6. Subunit composition of AMPD varies in response to changes in AMPD1 and AMPD3 gene expression in skeletal muscle.
    Fortuin FD, Morisaki T, Holmes EW.
    Proc Assoc Am Physicians; 1996 Jul; 108(4):329-33. PubMed ID: 8863347
    [Abstract] [Full Text] [Related]

  • 7. A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population.
    Gross M, Rötzer E, Kölle P, Mortier W, Reichmann H, Goebel HH, Lochmüller H, Pongratz D, Mahnke-Zizelman DK, Sabina RL.
    Neuromuscul Disord; 2002 Aug; 12(6):558-65. PubMed ID: 12117480
    [Abstract] [Full Text] [Related]

  • 8. The effect of AMPD1 genotype on blood flow response to sprint exercise.
    Norman B, Nygren AT, Nowak J, Sabina RL.
    Eur J Appl Physiol; 2008 May; 103(2):173-80. PubMed ID: 18224333
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Variation in the gene for muscle-specific AMP deaminase is associated with insulin clearance, a highly heritable trait.
    Goodarzi MO, Taylor KD, Guo X, Quiñones MJ, Cui J, Li X, Hang T, Yang H, Holmes E, Hsueh WA, Olefsky J, Rotter JI.
    Diabetes; 2005 Apr; 54(4):1222-7. PubMed ID: 15793265
    [Abstract] [Full Text] [Related]

  • 12. AMPD1: a novel therapeutic target for reversing insulin resistance.
    Cheng J, Morisaki H, Toyama K, Sugimoto N, Shintani T, Tandelilin A, Hirase T, Holmes EW, Morisaki T.
    BMC Endocr Disord; 2014 Dec 15; 14():96. PubMed ID: 25511531
    [Abstract] [Full Text] [Related]

  • 13. DNA sequence polymorphism within the bovine adenosine monophosphate deaminase 1 (AMPD1) is associated with production traits in Chinese cattle.
    Wei CB, Wang JQ, Chen FY, Niu H, Li K.
    Genet Mol Res; 2015 Feb 06; 14(1):1025-33. PubMed ID: 25730042
    [Abstract] [Full Text] [Related]

  • 14. Skeletal muscle contraction kinetics and AMPK responses are modulated by the adenine nucleotide degrading enzyme AMPD1.
    Hafen PS, Law AS, Matias C, Miller SG, Brault JJ.
    J Appl Physiol (1985); 2022 Nov 01; 133(5):1055-1066. PubMed ID: 36107988
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of AMPD1 gene polymorphism on muscle activity in humans.
    Fedotovskaya ON, Danilova AA, Akhmetov II.
    Bull Exp Biol Med; 2013 Feb 01; 154(4):489-91. PubMed ID: 23486588
    [Abstract] [Full Text] [Related]

  • 17. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
    Gastmann A, Sigusch HH, Henke A, Reinhardt D, Surber R, Gastmann O, Figulla HR.
    Am J Cardiol; 2004 May 15; 93(10):1260-4. PubMed ID: 15135700
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure.
    Loh E, Rebbeck TR, Mahoney PD, DeNofrio D, Swain JL, Holmes EW.
    Circulation; 1999 Mar 23; 99(11):1422-5. PubMed ID: 10086964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.